Anna Schwendenwein
- Oncology top 10%
- Lung Cancer Research Studies 6
- Pancreatic and Hepatic Oncology Research 2
- Peptidase Inhibition and Analysis 2
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Neuroendocrine Tumor Research Advances 6
-
- Cancer therapeutics and mechanisms 1
- TGF-β signaling in diseases 1
-
- Neuroblastoma Research and Treatments 1
- Co-authors
- Balázs DömeF Rényi-VámosZsolt MegyesfalviChristian LangKonrad HöetzeneckerKarin SchelchKristiina BoettigerHelmut Popper
- Cited by
- OncologyEpidemiologyCancer Research
In The Last Decade
Anna Schwendenwein
7 papers receiving 319 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 240
- Epidemiology 145
- Cancer Research 38
- Pulmonary and Respiratory Medicine 75
- Molecular Biology 113
Countries citing papers authored by Anna Schwendenwein
This map shows the geographic impact of Anna Schwendenwein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schwendenwein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schwendenwein more than expected).
Fields of papers citing papers by Anna Schwendenwein
This network shows the impact of papers produced by Anna Schwendenwein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schwendenwein. The network helps show where Anna Schwendenwein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Schwendenwein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directionsbreakdown → | 2023 | 179 |
| 3 | 2022 | 13 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 87 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 21 |
About Anna Schwendenwein
Anna Schwendenwein is a scholar working on Oncology, Epidemiology and Neurology, having authored 7 papers that have together received 322 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Research Studies (6 papers), Pancreatic and Hepatic Oncology Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Neuroblastoma Research and Treatments (1 paper), Cancer therapeutics and mechanisms (1 paper), TGF-β signaling in diseases (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Oncology (240 citations), Epidemiology (145 citations) and Cancer Research (38 citations). Anna Schwendenwein has collaborated with scholars based in Austria, Hungary and Sweden. Frequent co-authors include Balázs Döme, F Rényi-Vámos, Zsolt Megyesfalvi, Christian Lang, Konrad Höetzenecker, Karin Schelch, Kristiina Boettiger, Helmut Popper, Fred R. Hirsch and Lauren A. Byers. Their work appears in journals such as CA A Cancer Journal for Clinicians, Lung Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.